SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549



                                    FORM 8-K



                CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF
                       THE SECURITIES EXCHANGE ACT OF 1934



  Date of Report (Date of earliest event reported):          SEPTEMBER 18, 2002



                          WORLDWIDE MEDICAL CORPORATION
             (Exact name of registrant as specified in its charter)



             DELAWARE                   000-33263           33-0601331
          (State or other             (Commission        (I.R.S. Employer
   jurisdiction of incorporation)     File Number)      Identification No.)


                         13 SPECTRUM POINTE DRIVE
                            LAKE FOREST, CA               92630
              (Address of principal executive offices)  (zip code)


                                 (949) 598-8378
              (Registrant's telephone number, including area code)


          (Former name or former address, if changed since last report.)

<PAGE>

ITEM  1.          CHANGES  IN  CONTROL  OF  REGISTRANT

     Not  applicable.

ITEM  2.          ACQUISITION  OR  DISPOSITION  OF  ASSETS

     Not  applicable.

ITEM  3.          BANKRUPTCY  OR  RECEIVERSHIP

     Not  applicable.

ITEM  4.          CHANGES  IN  REGISTRANT'S  CERTIFYING  ACCOUNTANT

     Not  applicable.

ITEM  5.          OTHER  EVENTS

Financing
---------

     On  September  18, 2002, Worldwide Medical Corporation closed on $1,650,000
of financing with Ziegler Healthcare Fund I, L.P. ("Ziegler.")  The financing is
a  five  year  note,  bearing  interest  at  the  rate of 14% with interest-only
payments  in  year  one  and  secured  by  a  first  priority lien on all of the
Company's  tangible  and  intangible assets.  The note is fully amortized at the
end  of year five.  The note allows for pre-payment with a penalty of between 1%
and  5%  depending  on  when  the  pre-payment  occurs.  In  connection with the
financing, the Company issued to Ziegler warrants to acquire 2,598,053 shares of
common  stock,  subject  to  anti-dilution  protection as to price and as to the
number  of  shares  generally,  at an exercise price of $0.10 per share, but the
warrants  may  not  be  exercised unless the price of the Company's common stock
exceeds  $0.20.  The  warrants  are  exercisable  beginning  one  year  from the
closing.

     Net  loan  proceeds  to  the Company, after costs and fees of approximately
$187,000,  were  $1,463,000.  The  proceeds  will  be utilized by the Company as
follows:  approximately  $453,000 (plus approximately $199,000 in Company common
stock)  was used  to retire  approximately $987,000 in liabilities; $450,000 was
used  to  pay  down  approximately  $772,000  in  liabilities, and the creditors
holding  the  balance  of  these  liabilities executed forbearance agreements in
which  they  have agreed to refrain from bringing any claims against the Company
for  failure  by  the  Company  to pay its debt to such creditor when due and to
receive monthly payments based on a cash flow formula that allows the Company to
pay Ziegler and its current operating expenses and to maintain certain financial
covenants  prior  to  paying any of such creditors; $50,000 was utilized to make
the  Company's  scheduled  payment due the FDA; $416,666 has been deposited in a
restricted  account  for  use  in  investing  in  new business opportunities and
certain  other purposes, all as approved by Ziegler from time to time during the
term  of the financing; and the remaining approximately $93,000 will be used for
working  capital.

                                        2
<PAGE>

Resignation  of  Directors
--------------------------

     On  September  13,  2002,  Mr.  Glenn  G. Barrons resigned as Secretary and
Director  of  the  Company.  Mr.  Barrons'  resignation  came as a result of his
desire  to  devote  all  of  his focus to the development and operation of Cyber
Marketing  Concepts,  a  current  and  growing  customer  of  Worldwide  Medical
Corporation.  Mr.  Barrons  is  a  principal  of  Cyber  Marketing  Concepts.

     Effective  September 18, 2002, and in connection with the Ziegler financing
discussed above, Dr. Jemo Kang and Mr. Jeffrey H. Nicholas resigned as Directors
of the Company.  The resignation of both Dr. Kang and Mr. Nicholas was part of a
settlement and restructuring agreement with Princeton Biomeditech Corporation, a
creditor of the Company whose debt from the Company was satisfied as part of the
Ziegler  financing  transaction.

     To  the  best  knowledge  of  the  Company,  none  of  the above-referenced
directors  resigned  because  of  a  disagreement with the Company on any matter
relating  to  the  Company's  operations,  polices  or  practices.

Employment  Agreements
----------------------

     On  September  18,  2002,  and in connection with and as a condition of the
Ziegler  financing  discussed  above,  the  Company  entered into three (3) year
employment  agreements  beginning  October  1,  2002  with each of Mr. Daniel G.
McGuire,  President,  Mr.  Kevin  J.  Gadawski, Chief Financial Officer, and Mr.
Francisco  Rojas,  Chief  Scientific  Officer.

ITEM  6.          RESIGNATIONS  OF  DIRECTORS  AND  EXECUTIVE  OFFICERS

     Not  applicable.

ITEM  7.          FINANCIAL  STATEMENTS

     Not  applicable.

ITEM  8.          CHANGE  IN  FISCAL  YEAR

     Not  applicable.

                                        3
<PAGE>

EXHIBITS

<TABLE>
<CAPTION>


<S>       <C>
ITEM NO.  DESCRIPTION
--------  -----------

10.1 . .  Loan Agreement dated September 18, 2002 by and between the Company and Ziegler Healthcare Fund I, L.P.

10.2 . .  Promissory Note dated September 18, 2002 in favor of Ziegler Healthcare Fund I, L.P.

10.3 . .  Warrant Agreement dated September 18, 2002 in favor of Ziegler Healthcare Fund I, L.P.

10.4      Rights Agreement dated September 18, 2002 by and between the Company and Ziegler Healthcare Fund I, L.P.,
          and certain shareholders of the Company.

10.5 . .  Security Agreement dated September 18, 2002 by and between the Company and Ziegler Healthcare Fund I, L.P.

10.6      Assignment and Pledge of Deposit Account dated September 18, 2002 by and between the Company and
          Ziegler Healthcare Fund I, L.P.

10.7 . .  Employment Agreement dated September 18, 2002 by and between the Company and Daniel G. McGuire.

10.8 . .  Employment Agreement dated September 18, 2002 by and between the Company and Kevin J. Gadawski.

10.9 . .  Employment Agreement dated September 18, 2002 by and between the Company and Francisco Rojas.
</TABLE>

                                        4
<PAGE>
                                   SIGNATURES

     Pursuant  to  the  requirements of the Securities Exchange Act of 1934, the
Registrant  has  duly  caused  this  report  to  be  signed on its behalf by the
undersigned  hereunto  duly  authorized.

Dated:  October  1,  2002                    Worldwide  Medical  Corporation
                                             a  California  corporation


                                             /s/ Daniel G. McGuire
                                             ________________________________
                                             Daniel  G.  McGuire,  President

                                        5
<PAGE>
[{"type": "8-K", "sequence": "1", "filename": "doc1.txt", "secsgml_size_bytes": 7433}]
{"company-data": {"conformed-name": "WORLDWIDE MEDICAL CORP/CA/", "cik": "0001159544", "assigned-sic": "2835", "irs-number": "621658205", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-33263", "film-number": "02779465"}, "business-address": {"street1": "13 SPECTRUM POINTE DR", "city": "LAKE FOREST", "state": "CA", "zip": "92630", "phone": "9495988378"}, "mail-address": {"street1": "13 SPECTRUM POINTE DR", "city": "LAKE FOREST", "state": "CA", "zip": "92630"}}
SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549

                                    FORM 8-K

                CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

  Date of Report (Date of earliest event reported):          SEPTEMBER 18, 2002

                          WORLDWIDE MEDICAL CORPORATION
             (Exact name of registrant as specified in its charter)

             DELAWARE                   000-33263           33-0601331
          (State or other             (Commission        (I.R.S. Employer
   jurisdiction of incorporation)     File Number)      Identification No.)

                         13 SPECTRUM POINTE DRIVE
                            LAKE FOREST, CA               92630
              (Address of principal executive offices)  (zip code)

                                 (949) 598-8378
              (Registrant's telephone number, including area code)

          (Former name or former address, if changed since last report.)
ITEM  1.          CHANGES  IN  CONTROL  OF  REGISTRANT

     Not  applicable.

ITEM  2.          ACQUISITION  OR  DISPOSITION  OF  ASSETS

     Not  applicable.

ITEM  3.          BANKRUPTCY  OR  RECEIVERSHIP

     Not  applicable.

ITEM  4.          CHANGES  IN  REGISTRANT'S  CERTIFYING  ACCOUNTANT

     Not  applicable.

ITEM  5.          OTHER  EVENTS

Financing
---------

     On  September  18, 2002, Worldwide Medical Corporation closed on $1,650,000
of financing with Ziegler Healthcare Fund I, L.P. ("Ziegler.")  The financing is
a  five  year  note,  bearing  interest  at  the  rate of 14% with interest-only
payments  in  year  one  and  secured  by  a  first  priority lien on all of the
Company's  tangible  and  intangible assets.  The note is fully amortized at the
end  of year five.  The note allows for pre-payment with a penalty of between 1%
and  5%  depending  on  when  the  pre-payment  occurs.  In  connection with the
financing, the Company issued to Ziegler warrants to acquire 2,598,053 shares of
common  stock,  subject  to  anti-dilution  protection as to price and as to the
number  of  shares  generally,  at an exercise price of $0.10 per share, but the
warrants  may  not  be  exercised unless the price of the Company's common stock
exceeds  $0.20.  The  warrants  are  exercisable  beginning  one  year  from the
closing.

     Net  loan  proceeds  to  the Company, after costs and fees of approximately
$187,000,  were  $1,463,000.  The  proceeds  will  be utilized by the Company as
follows:  approximately  $453,000 (plus approximately $199,000 in Company common
stock)  was used  to retire  approximately $987,000 in liabilities; $450,000 was
used  to  pay  down  approximately  $772,000  in  liabilities, and the creditors
holding  the  balance  of  these  liabilities executed forbearance agreements in
which  they  have agreed to refrain from bringing any claims against the Company
for  failure  by  the  Company  to pay its debt to such creditor when due and to
receive monthly payments based on a cash flow formula that allows the Company to
pay Ziegler and its current operating expenses and to maintain certain financial
covenants  prior  to  paying any of such creditors; $50,000 was utilized to make
the  Company's  scheduled  payment due the FDA; $416,666 has been deposited in a
restricted  account  for  use  in  investing  in  new business opportunities and
certain  other purposes, all as approved by Ziegler from time to time during the
term  of the financing; and the remaining approximately $93,000 will be used for
working  capital.

                                        2
Resignation  of  Directors
--------------------------

     On  September  13,  2002,  Mr.  Glenn  G. Barrons resigned as Secretary and
Director  of  the  Company.  Mr.  Barrons'  resignation  came as a result of his
desire  to  devote  all  of  his focus to the development and operation of Cyber
Marketing  Concepts,  a  current  and  growing  customer  of  Worldwide  Medical
Corporation.  Mr.  Barrons  is  a  principal  of  Cyber  Marketing  Concepts.

     Effective  September 18, 2002, and in connection with the Ziegler financing
discussed above, Dr. Jemo Kang and Mr. Jeffrey H. Nicholas resigned as Directors
of the Company.  The resignation of both Dr. Kang and Mr. Nicholas was part of a
settlement and restructuring agreement with Princeton Biomeditech Corporation, a
creditor of the Company whose debt from the Company was satisfied as part of the
Ziegler  financing  transaction.

     To  the  best  knowledge  of  the  Company,  none  of  the above-referenced
directors  resigned  because  of  a  disagreement with the Company on any matter
relating  to  the  Company's  operations,  polices  or  practices.

Employment  Agreements
----------------------

     On  September  18,  2002,  and in connection with and as a condition of the
Ziegler  financing  discussed  above,  the  Company  entered into three (3) year
employment  agreements  beginning  October  1,  2002  with each of Mr. Daniel G.
McGuire,  President,  Mr.  Kevin  J.  Gadawski, Chief Financial Officer, and Mr.
Francisco  Rojas,  Chief  Scientific  Officer.

ITEM  6.          RESIGNATIONS  OF  DIRECTORS  AND  EXECUTIVE  OFFICERS

     Not  applicable.

ITEM  7.          FINANCIAL  STATEMENTS

     Not  applicable.

ITEM  8.          CHANGE  IN  FISCAL  YEAR

     Not  applicable.

                                        3
EXHIBITS
ITEM NO.  DESCRIPTION
--------  -----------

10.1 . .  Loan Agreement dated September 18, 2002 by and between the Company and Ziegler Healthcare Fund I, L.P.

10.2 . .  Promissory Note dated September 18, 2002 in favor of Ziegler Healthcare Fund I, L.P.

10.3 . .  Warrant Agreement dated September 18, 2002 in favor of Ziegler Healthcare Fund I, L.P.

10.4      Rights Agreement dated September 18, 2002 by and between the Company and Ziegler Healthcare Fund I, L.P.,
          and certain shareholders of the Company.

10.5 . .  Security Agreement dated September 18, 2002 by and between the Company and Ziegler Healthcare Fund I, L.P.

10.6      Assignment and Pledge of Deposit Account dated September 18, 2002 by and between the Company and
          Ziegler Healthcare Fund I, L.P.

10.7 . .  Employment Agreement dated September 18, 2002 by and between the Company and Daniel G. McGuire.

10.8 . .  Employment Agreement dated September 18, 2002 by and between the Company and Kevin J. Gadawski.

10.9 . .  Employment Agreement dated September 18, 2002 by and between the Company and Francisco Rojas.
4
SIGNATURES

     Pursuant  to  the  requirements of the Securities Exchange Act of 1934, the
Registrant  has  duly  caused  this  report  to  be  signed on its behalf by the
undersigned  hereunto  duly  authorized.

Dated:  October  1,  2002                    Worldwide  Medical  Corporation
                                             a  California  corporation

                                             /s/ Daniel G. McGuire
                                             ________________________________
                                             Daniel  G.  McGuire,  President

                                        5